Elevated site urgencyFDA Class II

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc

Failed Dissolution Specifications: below specification

Agency
FDA Drug
Recall date
Sep 17, 2026
Status
Ongoing
Company
Ajanta Pharma USA Inc

1. What product was recalled?

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Code or lot text: Lot: DJ25134, Exp 11/30/2028

LOT
Exp 11/30/2028
LOT
Lot: DJ25134
NDC
27241-125
NDC
27241-125-02
NDC
27241-125-05
NDC
27241-126
NDC
27241-126-02
NDC
27241-126-05
RECALL-NUMBER
D-0010-2027
UPC
0327241125027
UPC
0327241126024

2. Is my exact product affected?

Compare every printed identifier. A matching value can indicate that your product is included.

3. What is the hazard?

Failed Dissolution Specifications: below specification

4. What should I do now?

Follow the FDA recall notice and contact the recalling company for current instructions.

5. Where was it sold or distributed?

Nationwide

6. Were injuries or illnesses reported?

No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.

7. What remedy is available?

Follow the FDA recall notice and contact the recalling company for current instructions.

8. Is the recall active or closed?

The source status is Ongoing. The Recall Guy's urgency label is elevated, which is a separate deterministic site label.

9. When was the information checked?

Last checked .

  1. created

10. Where is the official source?

Open the official FDA Drug source

The Recall Guy normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.